| Literature DB >> 27759030 |
Fanny Morice-Picard1,2, Giovanni Benard3, Hamid R Rezvani4, Eulalie Lasseaux5, Delphine Simon3, Sébastien Moutton3, Caroline Rooryck3,5, Didier Lacombe3, Clarisse Baumann6, Benoit Arveiler3,5.
Abstract
The ubiquitin-proteasome pathway is involved in the pathogenesis of several neurogenetic diseases. We describe a Mauritanian patient harboring a homozygous deletion restricted to two contiguous genes HERC2 and OCA2 and presenting with severe developmental abnormalities. The deletion causes the complete loss of HERC2 protein function, an E3-ubiquitin ligase. HERC2 is known to target XPA and BRCA1 for degradation and a mechanism whereby it is involved in DNA repair and cell cycle regulation. We showed that loss of HERC2 function leads to the accumulation of XPA and BRCA1 in the patient's fibroblasts and generates decreased sensitivity to apoptosis and increased level of DNA repair. Our data describe for the first time the phenotypic consequences, both at the clinical and cellular levels, of a complete loss of HERC2 function in a patient. They strongly suggest that profound ubiquitin ligase - associated dysfunction is responsible for the severe phenotype in this patient, and that dysfunction of this pathway may be involved in other patients with similar neurodevelopmental diseases.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27759030 PMCID: PMC5159772 DOI: 10.1038/ejhg.2016.139
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246